Valuation dashboard for Cumberland Pharmaceuticals Inc. (CPIX) with P/E N/A, P/B 6.05, EV/EBITDA -17.72 and dividend yield 21.30%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastroenterology, rheumatology, and oncology, with operations spanning both the United States and global markets. The company's existing product line includes: Acetadote: an injectable solution for treating acetaminophen poisoning.
Analysis Summary
Cumberland Pharmaceuticals Inc. reported revenue of $44.5M in the most recent fiscal year, growing at a 5-year CAGR of 3.5%.
Trailing-twelve-month margins: gross margin 83.4%, operating margin -30.8%, net margin -33.9%.
At the current price of $6.98, CPIX has negative trailing earnings (P/E not meaningful) and an ROE of -47.10%. Market capitalisation stands at $105M.
Balance sheet quality for CPIX: current ratio of 1.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 6.05 |
| EV / EBITDA | -17.72 |
| Dividend Yield | 21.30% |
Valuation Models
| DCF Fair Value | $1.07 |
| vs Current Price | -84.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CPIX | Cumberland Pharmaceuticals Inc. | $105M | 6.05 | -47.1% | |
| TAK | Takeda Pharmaceutical Company Limited | $59.4B | 51.19 | 1.21 | 2.6% |
| TEVA | Teva Pharmaceutical Industries Limited | $45.0B | 61.47 | 5.82 | 17.8% |
| HLN | Haleon plc | $40.5B | 18.64 | 1.84 | 9.9% |
| 0M3Q.L | Zoetis Inc. | $35.4B | |||
| ZTS | Zoetis Inc. | $30.6B | 11.99 | 9.67 | 69.3% |
| HLN.L | Haleon plc | $29.4B | 18.73 | 1.85 | 9.9% |
| 0SAN.L | Sandoz Group AG | $28.3B | 52.81 | 3.84 | 7.0% |
Price
| Price | $6.98 |
| Market Cap | $105M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -47.10% |
| Return on Invested Capital | -34.15% |
| Return on Assets | -16.87% |
| Gross Margin | 83.37% |
| Operating Margin | -30.79% |
| Net Margin | -33.92% |
Related companies: ABVC · CALC · CELU · DYAI · LTRN · LVTX · NOTV
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of CPIX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks